Editorially Independent Content, Supported With Advertising From Astellas and Carl Zeiss Meditec
David RP Almeida, MD, PhD, MBA; Chris Riemann, MD; and Lisa Faia, MD
Show Description +
How are high-volume retina specialists selecting which real-world patients are best suited for geographic atrophy treatment? David RP Almeida, MD, PhD, MBA, explores this topic with Chris Riemann, MD, and Lisa Faia, MD, and examines which clinical features are best suited to treatment, whether non-clinical patient characteristics drive treatment decisions, and which real-world barriers to care are most challenging to overcome.
Posted: 5/03/2024
David RP Almeida, MD, PhD, MBA; Chris Riemann, MD; and Lisa Faia, MD
How are high-volume retina specialists selecting which real-world patients are best suited for geographic atrophy treatment? David RP Almeida, MD, PhD, MBA, explores this topic with Chris Riemann, MD, and Lisa Faia, MD, and examines which clinical features are best suited to treatment, whether non-clinical patient characteristics drive treatment decisions, and which real-world barriers to care are most challenging to overcome.
Posted: 5/03/2024
Please log in to leave a comment.